Tepper reappointed to Clinical Trials Advisory Board

Extends his previous four-year term.

Tepper reappointed to Clinical Trials Advisory Board click to enlarge Dr. Joel Tepper

Joel Tepper, M.D., Ph.D. has been reappointed to a two-year term (an extension of his previous four-year term) on the Clinical Trials and Translational Research Advisory Committee, an advisory committee to the Director of the National Cancer Institute (NCI), charged with oversight of the NCI clinical trials and translational research portfolio.

Filed under: ,